SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-21-054811
Filing Date
2021-02-24
Accepted
2021-02-24 17:00:13
Documents
94
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d53064d10k.htm   iXBRL 10-K 2724211
2 EX-4.3 d53064dex43.htm EX-4.3 15763
3 EX-21.1 d53064dex211.htm EX-21.1 1938
4 EX-23.1 d53064dex231.htm EX-23.1 7053
5 EX-31.1 d53064dex311.htm EX-31.1 6362
6 EX-31.2 d53064dex312.htm EX-31.2 6355
7 EX-32.1 d53064dex321.htm EX-32.1 4336
13 GRAPHIC g53064g56e40.jpg GRAPHIC 196297
14 GRAPHIC g53064g78p30.jpg GRAPHIC 121005
  Complete submission text file 0001193125-21-054811.txt   10794135

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA kpti-20201231.xsd EX-101.SCH 70940
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20201231_cal.xml EX-101.CAL 72068
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20201231_def.xml EX-101.DEF 342550
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20201231_lab.xml EX-101.LAB 609730
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20201231_pre.xml EX-101.PRE 503813
15 EXTRACTED XBRL INSTANCE DOCUMENT d53064d10k_htm.xml XML 1514883
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36167 | Film No.: 21674505
SIC: 2834 Pharmaceutical Preparations